British biotech firm hVIVO is in talks to create and provide strains of the Covid-19 virus which can be used for human challenge trials.
U.K. Government Reportedly In Advanced Talks To Initiate Human Challenge Vaccine Trials That Would See Volunteers Infected With Covid-19
